In the last trading session, 143.6 million shares of the Conduit Pharmaceuticals Inc (NASDAQ:CDT) were traded, and its beta was 2.17. Most recently the company’s share price was $2.85, and it changed around $1.3 or 83.87% from the last close, which brings the market valuation of the company to $6.05M. CDT currently trades at a discount to its 52-week high of $392.00, offering almost -13654.39% off that amount. The share price’s 52-week low was $1.45, which indicates that the current value has risen by an impressive 49.12% since then. We note from Conduit Pharmaceuticals Inc’s average daily trading volume that its 10-day average is 15.31 million shares, with the 3-month average coming to 661.34K.

Conduit Pharmaceuticals Inc (NASDAQ:CDT) trade information

Instantly CDT has showed a green trend with a performance of 83.87% at the end of last trading. The performance over the last five days has remained in the green territory. The rise to weekly highs of 3.70 on recent trading dayincreased the stock’s daily price by 22.97%. The company’s shares are currently down -58.45% year-to-date, but still up 14.92% over the last five days. On the other hand, Conduit Pharmaceuticals Inc (NASDAQ:CDT) is -69.68% down in the 30-day period. We can see from the shorts that 3.57 million shares have been sold at a short interest cover period of 0.14 day(s).

CDT Dividends

Conduit Pharmaceuticals Inc’s next quarterly earnings report is expected to be released in March.

Conduit Pharmaceuticals Inc (NASDAQ:CDT)’s Major holders

Upon looking at major shareholders, it appears that insiders hold 49.12% of Conduit Pharmaceuticals Inc shares, and 4.06% of them are in the hands of institutional investors. The stock currently has a share float of 7.97%.